Search for Abstracts Find by Title, Author or Description Year Abstracts - 2025 - 2024 - 2023 - 2022 - 2021 - 2020 - 2019 - 2018 - 2017 - 2016 - 2015 - 2014 - 2013 - 2012 - 2011 - 2010 - 2009 Tags AB Applied Basic Science Basic Science BT Clinical Clinical-Chemotherapy-SSA-Biologics Clinical-NuclearMedicine-InterventionalRadiology-Imaging Clinical-PRRT-Nuclear Clinical-Surgical-Applied_Pathology O OT Other P Population Science Poster T Trials In Progress Search Reset Order by Title Alphabetical Title Reverse Alphabetical Most Recent First Oldest First Most popular first Last modified first [B10] Sullivan - Allosteric ClpP agonist ONC206 alters mitochondrial metabolism, stress response and chromatin accessibility to elicit apoptosis in pheochromocytoma Published in 2025 Listed under Basic Science Download [B11] Dickerson - Mechanisms and Models for Cdk5 dependent Neuroendocrine Tumors Published in 2025 Listed under Applied Basic Science Download [B12] Santoro Fernades - Influence of patient cohort size on PFS prediction accuracy using baseline SSTR image models Published in 2025 Listed under Applied Basic Science Download [B13] Gupta - Claudin 18 2 in pancreatic neuroendocrine tumors a potential therapeutic target Published in 2025 Listed under Applied Basic Science Download [B14] Partelli - Advanced 3D preclinical models of pancreatic neuroendocrine tumors from bioprinting to precision cut tumor slices Published in 2025 Listed under Applied Basic Science Download [B1] Pollin - Spatial and Transcriptional Profiling Reveals Immune Remodeling and Microenvironmental Heterogeneity in Benign and Malignant Pancreatic Neuroendocrine Tumors Published in 2025 Listed under Basic Science Download [B2] Gillis (POSTER) - Validation of Adversity Linked Genes in Pancreatic Neuroendocrine Tumors Published in 2025 Listed under Basic Science Download [B2] Gillis - Validation of Adversity Linked Genes in Pancreatic Neuroendocrine Tumors Published in 2025 Listed under Basic Science Download [B3] Pelle - A SST14 based T cell engager for the treatment of neuroendocrine tumors Published in 2025 Listed under Basic Science Download [B4] Mäkinen - Single nucleus transcriptomic analysis of the tumor microenvironment in small intestinal NETs Published in 2025 Listed under Basic Science Download [B5] Gorai - Uncovering Filamin A as an Exosomal Biomarker in PanNET Through Integrative Tissue Proteomics Published in 2025 Listed under Basic Science Download [B6] Madigan - Tumor Intrinsic Adaptations to Liver Microenvironment Drive Metastasis in Pancreatic and Small Intestinal Neuroendocrine Tumors Published in 2025 Download [B7] Abbu - Changes in the Tumor Microenvironment of Well Differentiated Metastatic Neuroendocrine Tumors might mediate resistance in patients treated with 177Lu DOTATATE Published in 2025 Listed under Basic Science Download [B8] Hines - Deciphering the Functionality of MAX Phosphorylation Dynamics in Pancreatic Neuroendocrine Tumors Published in 2025 Listed under Basic Science Download [B9] Yogo - Spatial Transcriptomics Reveals Local Subtype Specific Identity and Signaling within Multifocal Small Intestinal Neuroendocrine Tumors Published in 2025 Listed under Basic Science Download [C10] Sahwan - The Efficacy of Low dose vs Standard dose Everolimus in Patients with Advanced Neuroendocrine Tumors Published in 2025 Listed under Clinical-Chemotherapy-SSA-Biologics Download [C11] Cass - The useful combination of capecitabine and temozolomide (CAPTEM) in metastatic lung carcinoid tumors Published in 2025 Listed under Clinical-Chemotherapy-SSA-Biologics Download [C12] Soulen (POSTER) - Randomized Embolization Trial for NeuroEndocrine Tumors (RETNET) Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C12] Soulen - Randomized Embolization Trial for NeuroEndocrine Tumors (RETNET) Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C13] Thuemmler (POSTER) - Safety and clinical implications of concurrent biopsy of neuroendocrine liver metastases at the time of liver directed therapy Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C13] Thuemmler - Safety and clinical implications of concurrent biopsy of neuroendocrine liver metastases at the time of liver directed therapy Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C14] Capdevila Castillon - Efficacy of 177Lu edotreotide vs everolimus in patients with grade 1 or grade 2 GEP NETs Phase 3 COMPETE trial (post hoc subgroup analyses) Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C15] Maluccio - Long term Follow up of PRRT Naïve Patients with GEP NETs Treated with Targeted Alpha Therapy 212Pb DOTAMTATE in the Phase 2 ALPHAMEDIX 02 Trial Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C16] Strosberg - Phase 2 Study of Targeted Alpha Therapy 212Pb DOTAMTATE in Patients with Advanced Gastroenteropancreatic (GEP) NETs Previously Treated with PRRT Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C17] Nicolas - 61Cu NODAGA LM3 versus 68Ga DOTATOC in the same patients with neuroendocrine tumors Preliminary results of the Phase I II COPPER PET in NET Trial Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C18] Tesfaye (POSTER) - Patient Characteristics and Treatment Patterns With [177Lu]Lu DOTA TATE (177Lu DOTATATE) In the US A Real World Assessment Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C18] Tesfaye - Patient Characteristics and Treatment Patterns With [177Lu]Lu DOTA TATE (177Lu DOTATATE) In the US A Real World Assessment Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C19] Halfdanarson - [212Pb]VMT alpha NET for advanced SSTR+ NETs safety and preliminary efficacy results from cohorts 1 and 2 of the dose escalation phase Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C1] Capdevila Castillon - An ongoing phase 1 trial of obrixtamig in patients with extrapulmonary neuroendocrine carcinomas with high or low DLL3 expression Published in 2025 Listed under Clinical-Chemotherapy-SSA-Biologics Download [C20] Chauhan - Multi center NCI sponsored phase 1 study of triapine in combination with 177Lu dotatate in patients with progressive well differentiated gastroenteropancreatic neuroendocrine tumors (GEP NETs) Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C21] Ali (POSTER) - Single institution experience with [131I]MIBG for pheochromocytoma and paraganglioma Long term outcomes and dosimetry Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C21] Ali - Single institution experience with [131I]MIBG for pheochromocytoma and paraganglioma Long term outcomes and dosimetry Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C22] Ghanta - Systematic Literature Review and Radiomics Quality Assessment for Lung, Adrenal, Thyroid and Pituitary Neuroendocrine Tumors Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C23] Fricke - Efficacy and safety of [177Lu]Lu edotreotide ([177Lu]Lu DOTATOC) for the treatment of neuroendocrine tumors (NETs) – a systematic literature review (SLR) and meta analysis Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C24] Nicolas - First line Treatment with [177Lu]Lu edotreotide ([177Lu]Lu DOTATOC) in patients with NETs a SwissNET Registry Analysis Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C25] Fidelman (POSTER) - Safety of Transarterial Liver Directed Therapy for Metastatic Neuroendocrine Tumor for Patients with Carcinoid Heart Disease Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C25] Fidelman - Safety of Transarterial Liver Directed Therapy for Metastatic Neuroendocrine Tumor for Patients with Carcinoid Heart Disease Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C26] Koch (POSTER) - Clinical outcomes following salvage PRRT in patients with metastatic neuroendocrine tumors Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C26] Koch - Clinical outcomes following salvage PRRT in patients with metastatic neuroendocrine tumors Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C27] Chauhan (POSTER) - Efficacy and Safety of Peptide Receptor Radionuclide Therapy Retreatment (r PRRT) Practices in Progressive Neuroendocrine Tumors (prog NETs) Systematic Review and Meta Analysis Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C27] Chauhan - Efficacy and Safety of Peptide Receptor Radionuclide Therapy Retreatment (r PRRT) Practices in Progressive Neuroendocrine Tumors (prog NETs) Systematic Review and Meta Analysis Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C29] Mittra - Liver directed therapy for metastatic neuroendocrine carcinoma and grade 3 well differentiated neuroendocrine tumors Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C2] Mohindroo - Prognostic Significance of MEN1, ATRX, and DAXX Mutations in Pancreatic Neuroendocrine Tumors Treated with CAPTEM Insights from a Multicenter Cohort Published in 2025 Listed under Clinical-Chemotherapy-SSA-Biologics Download [C30] Sztangret (POSTER) - DISCO Safety, Tolerability and Diagnostic performance of 64Cu SARTATE compared to 68Ga DOTATATE in patients with known or suspected neuroendocrine tumors Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C30] Sztangret - DISCO Safety, Tolerability and Diagnostic performance of 64Cu SARTATE compared to 68Ga DOTATATE in patients with known or suspected neuroendocrine tumors Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C32] Cass - Incidence of Peripheral Inserted Central Line Complications with Administration of 177Lutetium Dotatate Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C33] Al-Toubah (POSTER) - Somatostatin receptor expression on 68Ga Dotatate imaging among patients with poorly differentiated extra pulmonary neuroendocrine carcinomas a prospective study Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C33] Al-Toubah - Somatostatin receptor expression on 68Ga Dotatate imaging among patients with poorly differentiated extra pulmonary neuroendocrine carcinomas a prospective study Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C34] Goa - Outcomes of Peptide Receptor Radionuclide Therapy in Patients with Pheochromocytoma and Paraganglioma A Center of Excellence Experience Published in 2025 Listed under Clinical-NuclearMedicine-InterventionalRadiology-Imaging Download [C35] Hallet - Care of Neuroendocrine Tumors the Collaborative of Surgical Teams for NeuroEndocrine Tumors (CUTNETs) Published in 2025 Listed under Clinical-Surgical-Applied_Pathology Download [C36] Chang - The Natural History of Small Bowel Neuroendocrine Tumor (SBNET) Metastases Published in 2025 Listed under Clinical-Surgical-Applied_Pathology Download [C37] Hallet - International expert consensus on perioperative management of carcinoid crisis Published in 2025 Listed under Clinical-Surgical-Applied_Pathology Download [C38] Shah - Association of Surgical Intervention with 30 Day Re admission and Outcomes in Patients Hospitalized for Small Bowel Neuroendocrine Tumor Related Obstruction Published in 2025 Listed under Clinical-Surgical-Applied_Pathology Download [C39] Laderian - Primary Tumor Resection Is Associated With Improved Survival in Metastatic GI NETs A Retrospective Study in the Bronx, NY Published in 2025 Listed under Clinical-Surgical-Applied_Pathology Download [C3] Mohamed - Investigator Assessed Disease Progression in a Phase 2 Study of Paltusotine in Patients with Neuroendocrine Tumors and Carcinoid Syndrome Published in 2025 Listed under Clinical-Chemotherapy-SSA-Biologics Download [C40] Meloche-Dumas - Short term post operative outcomes after surgery for entero pancreatic neuroendocrine tumors (NETs) a population based analysis Published in 2025 Listed under Clinical-Surgical-Applied_Pathology Download [C41] Meloche-Dumas - Survival outcomes after surgery for entero pancreatic neuroendocrine tumors a population based analysis Published in 2025 Listed under Clinical-Surgical-Applied_Pathology Download [C42] Chang - Risk Factors and Prognosis of Peritoneal Metastases in Small Bowel Neuroendocrine Tumor Patients Published in 2025 Listed under Clinical-Surgical-Applied_Pathology Download [C43] Meloche-Dumas - Mapping the evidence for surgical care of gastro entero pancreatic neuroendocrine tumors a scoping review Published in 2025 Listed under Clinical-Surgical-Applied_Pathology Download [C44] Wornow - Resection of Primary Pancreatic Neuroendocrine Tumors in the Metastatic Setting Published in 2025 Listed under Clinical-Surgical-Applied_Pathology Download [C45] Sachdeva - Improving Outcomes for Neuroendocrine Patients 25 year review of 1699 NET Surgical Cytoreduction Patients at a Single Institution Published in 2025 Listed under Clinical-Surgical-Applied_Pathology Download [C46] Michelakos - Evaluating the role of postoperative long acting somatostatin analogue therapy in patients with metastatic neuroendocrine tumors undergoing surgical debulking Published in 2025 Listed under Clinical-Surgical-Applied_Pathology Download [C47] Andreasi - Role of Surgery in Patients with G1 G2 Pancreatic Neuroendocrine Tumors and Synchronous Liver Metastases Published in 2025 Listed under Clinical-Surgical-Applied_Pathology Download [C48] Andreasi - Pancreatic Neuroendocrine Tumors with Intraductal Growth Unraveling a Rare Entity Published in 2025 Listed under Clinical-Surgical-Applied_Pathology Download [C49] Said Abu Egal - Differential Expression of GLUT 1 and FASN Across Histological Grades of Pancreatic Neuroendocrine Neoplasms Published in 2025 Listed under Clinical-Surgical-Applied_Pathology Download [C4] Pirozzi - Multicenter Real World Study of Treatment Patterns in Well Differentiated Grade 3 (G3) Gastroenteropancreatic Neuroendocrine Tumors (GEP NETs) Published in 2025 Listed under Clinical-Chemotherapy-SSA-Biologics Download [C50] Battistella - Preoperative Predictors of New Onset Diabetes Mellitus Following Distal Pancreatectomy for Non functioning Pancreatic Neuroendocrine Tumours Published in 2025 Listed under Clinical-Surgical-Applied_Pathology Download [C5] Singh - PPM1D as a Potential Driver of Myeloid Malignancy Transformation in Neuroendocrine Tumor (NET) Pts An Underrecognized Malignant CHIPerpetrator Published in 2025 Listed under Clinical-Chemotherapy-SSA-Biologics Download [C6] Arshad - TROP2 Expression in the Gastroenteropancreatic Neuroendocrine Tumors; An analysis of 179 patients Published in 2025 Listed under Clinical-Chemotherapy-SSA-Biologics Download [C7] Halfdanarson - The Hidden Cost of Enzyme Therapy Oxalate Nephropathy in a NET Patient with Pancreatic Insufficiency Published in 2025 Listed under Clinical-Chemotherapy-SSA-Biologics Download [C8] Chauhan - DAREON® 7 Phase I open label dose escalation expansion study of first line obrixtamig (BI 764532) plus chemotherapy in patients with DLL3 positive neuroendocrine carcinomas Published in 2025 Listed under Clinical-Chemotherapy-SSA-Biologics Download [C9] Mohindroo - Somatic genomic profiling of gastrointestinal neuroendocrine tumors Implications for prognostication and therapeutic targeting Published in 2025 Listed under Clinical-Chemotherapy-SSA-Biologics Download [O10] Soares - Expanding Access to Neuroendocrine Tumor Care Early Impact of the University of Utah NET Destination Care Program Published in 2025 Listed under Other Download [O11] Ammabel Ynalvez - Preventing Early Bioprosthetic Valve Deterioration in Carcinoid Heart Disease A Case Series and Perioperative Management Strategy Published in 2025 Listed under Other Download [O12] Ueberroth - Molecular and Clinical Profiling of Gastroenteropancreatic Neuroendocrine Tumors (GEP NETs) An Analysis of the Oncology Research Information Exchange Network Database Published in 2025 Listed under Other Download [O13] Suresh - Peculiar Prostate Peculiarity Exploring Ectopic Cushing’s Disease in Prostate Neuroendocrine Carcinoma Published in 2025 Listed under Other Download [O1] Singh Grewal - Distinct Sociodemographic, Symptom, and HRQoL Profiles in Early Onset Neuroendocrine Tumors Insights from the NET PRO Study Published in 2025 Listed under Other Download [O2] Estrada (POSTER) - Analysis of patient selection for germline testing in early onset gastroenteropancreatic neuroendocrine neoplasms (GEPNENs) at a single institution Published in 2025 Listed under Other Download [O2] Estrada - Analysis of patient selection for germline testing in early onset gastroenteropancreatic neuroendocrine neoplasms (GEPNENs) at a single institution Published in 2025 Listed under Other Download [O3] AbiMansour - Clinical Features and Outcomes of Small and Very Small Pancreatic Neuroendocrine Tumors Published in 2025 Listed under Other Download [O4] Gujarathi - Real World Outcomes with Chemotherapy and Immunotherapy in Metastatic Poorly Differentiated Gastroenteropancreatic Neuroendocrine Carcinomas Published in 2025 Listed under Other Download [O5] Graboyes (POSTER) - Recurrent Tympanic Paragangliomas An Overview of Institutional Experience Published in 2025 Listed under Other Download [O5] Graboyes - Recurrent Tympanic Paragangliomas An Overview of Institutional Experience Published in 2025 Listed under Other Download [O6] Vaca - Effect of GLP 1 receptors agonists on progression free survival in patients with well differentiated neuroendocrine tumors treated with lanreotide Published in 2025 Listed under Other Download [O6] Vaca (POSTER) - Effect of GLP 1 receptors agonists on progression free survival in patients with well differentiated neuroendocrine tumors treated with lanreotide Published in 2025 Listed under Other Download [O7] Trikalinos - Treatment Sequence in Advanced Small Bowel Neuroendocrine Neoplasms A Simulation Study Published in 2025 Listed under Other Download [O8] Baskar - Symptom burden and outcomes among patients with early onset and average onset neuroendocrine neoplasms Published in 2025 Listed under Other Download [O9] Khamis - Neuroendocrine neoplasms diagnosed in the setting of inflammatory bowel disease An appraisal of published literature and proposed management algorithm Published in 2025 Listed under Other Download [P10] Chung - Racial and Gender Disparities in Neuroendocrine Tumors – A Retrospective Study Using a Single Institutional Database Published in 2025 Listed under Population Science Download [P1] O’Rorke - Quality of Life and Care Experiences in a U S Multi Institutional Neuroendocrine Tumor Cohort Published in 2025 Listed under Population Science Download [P2] Zheng (POSTER) - Racial and ethnic disparities in US neuroendocrine tumor clinical trial enrollment over the past quarter century Published in 2025 Listed under Population Science Download [P2] Zheng - Racial and ethnic disparities in US neuroendocrine tumor clinical trial enrollment over the past quarter century Published in 2025 Listed under Population Science Download [P3] Alnajar - Higher composite Social Determinants of Health scores predict worsened survival for early stage small bowel Neuroendocrine Tumors Published in 2025 Listed under Population Science Download [P4] Sun (POSTER) - Survival of colorectal small cell carcinoma and comparison with colorectal adenocarcinoma Published in 2025 Listed under Population Science Download [P4] Sun - Survival of colorectal small cell carcinoma and comparison with colorectal adenocarcinoma Published in 2025 Listed under Population Science Download [P5] Xu - Treatment Decision Concerns A Latent Class Analysis in Young Onset Neuroendocrine Tumors Published in 2025 Listed under Population Science Download [P6] Meloche-Dumas - Contemporary epidemiology of gastro entero pancreatic neuroendocrine neoplasms Published in 2025 Listed under Population Science Download [P7] Thomas - Germline Pathogenic Variants Among Participants with Neuroendocrine Tumors in the Healthy Nevada Project Published in 2025 Listed under Population Science Download [P8] Paciorek (POSTER) - Clinical details of early onset neuroendocrine neoplasms differ by race and ethnicity and overall differ from typical onset Published in 2025 Listed under Population Science Download [P8] Paciorek - Clinical details of early onset neuroendocrine neoplasms differ by race and ethnicity and overall differ from typical onset Published in 2025 Listed under Population Science Download Select the number of documents per page 5 10 15 20 25 30 50 100 12»
